Actively Recruiting
Optimization of Postoperative Adjuvant Therapy for Cervical Cancer Based on MRD(Minimal Residual Disease)
Led by Suzhou Municipal Hospital · Updated on 2023-05-24
32
Participants Needed
1
Research Sites
310 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is a prospective cohort clinical trial that aims to investigate the safety and efficacy of a combined chemoradiotherapy and immunotherapy treatment for early postoperative cervical cancer. Specifically, this study seeks to evaluate the ability of MRD-based screening to detect and monitor changes in MRD status at different stages of treatment, its potential for use in monitoring patient recurrence rates and in prognosis evaluation. In addition, this study will investigate the safety and effectiveness of chemoradiotherapy combined with immunotherapy as a postoperative adjuvant therapy for patients identified to be at risk of early cervical cancer based on MRD screening.
CONDITIONS
Official Title
Optimization of Postoperative Adjuvant Therapy for Cervical Cancer Based on MRD(Minimal Residual Disease)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with histopathological and clinical (FIGO 2018) stage IB2 to IIA2 cervical cancer.
- Age 18 years or older.
- ECOG performance status score of 0 to 2.
- Able to understand the study and voluntarily sign informed consent.
- Good compliance and able to provide specimens and clinical information as required.
You will not qualify if you...
- Having other malignant tumors.
- Not receiving the specified treatment or changing treatment before disease progression.
- Unable to follow the study's clinical follow-up schedule.
- Unable to accept or provide CT scans or other required therapeutic evaluations.
- Having an autoimmune disease.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Affiliated Suzhou Hospital of Nanjing Medical University
Suzhou, Jiangsu, China, 215001
Actively Recruiting
Research Team
J
jing xue
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here